Berwick DM Crossing the boundary: changing mental models in the service of improvement. Int J Qual Health Care. 1998 Oct;10(5):435-41.
Brubakk K, Vist GE, Bukholm G, Barach P, Tjomsland O A systematic review of hospital accreditation: the challenges of measuring complex intervention effects. BMC Health Serv Res. 2015 Jul 23;15:280. doi: 10.1186/s12913-015-0933-x. Review.
Flaatten H Epidemiology of sepsis in Norway in 1999. Crit Care. 2004 Aug;8(4):R180-4. Epub 2004 May 14.
Flodgren G, Pomey MP, Taber SA, Eccles MP Effectiveness of external inspection of compliance with standards in improving healthcare organisation behaviour, healthcare professional behaviour or patient outcomes. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008992. doi: 10.1002/14651858.CD008992.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 02;12 :CD008992.
Gatewood MO, Wemple M, Greco S, Kritek PA, Durvasula R A quality improvement project to improve early sepsis care in the emergency department. BMJ Qual Saf. 2015 Dec;24(12):787-95. doi: 10.1136/bmjqs-2014-003552. Epub 2015 Aug 6. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
